ClinicOps
Flagship · Regulatory Change Integrity Review

Turn one change into a reviewer-ready closure packet.

Give ClinicOps one controlled change and the records that should reflect it. You receive a traceable list of what matches, what is missing, what differs, who owns each open item, and what evidence closes it.

The Regulatory Change Integrity Review — the ClinicOps flagship engagement — starts with one approved or authoritative change and a defined evidence population. ClinicOps structures the source register, maps affected surfaces, reconciles available evidence, exposes unresolved questions and prepares the packet for accountable human review.

Human accountability stays explicit. ClinicOps structures and reconciles the evidence. Regulatory, clinical, legal, safety, quality and release decisions remain with the qualified owner.

What the pack contains

1. SOURCE REGISTER

Know what controls the change

Approved or authoritative source, version/date, provenance pointer, declared scope, assumptions and exclusions.

2. CHANGE-SURFACE MATRIX

See where the change should be checked

Declared systems, records, documents, sites, vendors or people with observed evidence state, owner and expected closure evidence.

3. UNRESOLVED QUEUE

Route uncertainty instead of hiding it

Missing evidence, ownership ambiguity, conflicting versions and interpretation questions are kept explicit and assigned to the right owner.

4. CLOSURE PACKET

Prepare accountable review

Signals are separated from judgements, closure references are kept, and unresolved items stay visible until the accountable owner decides or routes them.

5. PORTABLE HANDOFF

Avoid unnecessary platform dependence

Where practical, delivery uses portable human- and machine-readable formats such as HTML, JSON, CSV and Markdown rather than locking the evidence into one interface.

6. VERSIONED SCOPE

Keep the evidence population controlled

The pack is tied to the declared change event and evidence population so later additions or changes can be identified rather than silently mixed into the original review.

Where it fits

Primary market: medical-device RA/QA

Controlled regulatory sources reconciled against EUDAMED and UDI/master data, IFUs and labels, SS(C)P masters and translations, certificates, declarations and downstream handoffs — the surfaces described under use cases.

Partner channel: ARs & specialist consultancies

The same review applied across a managed manufacturer portfolio: triage records, detect missing evidence, produce portable evidence packets. The partner's qualified team makes the regulatory judgement.

The method travels to trials, quality systems, laboratory and content workflows, but ClinicOps sells it where the evidence is: EU MedTech regulatory data.

Minimum starting point

One change event
Approved source
Defined population
Evidence route
Accountable owner

If the scope is not yet clear, ClinicOps defines the evidence population first so the review starts from a controlled baseline.

Built for controlled change work

When an approved source changes, the work is proving which downstream records, systems, documents and owners were affected, then closing the gaps without losing traceability.

Clear operational output

A versioned source register, change-surface matrix, unresolved queue and closure packet, ready to review, hand over and act on.

Repeatable operating structure

The same structure serves the next change event; only the source set, review depth and decision owner change.

Start with evidence, not a sales deck

Use the free Change Surface Mapper to structure one live change. If the map reveals unresolved owners, missing evidence, conflicting versions or a meaningful reconciliation queue, carry that context into a ClinicOps scope brief.